Establishment Labs Holdings Inc. (NASDAQ:ESTA) Shares Purchased by Simplify Asset Management Inc.

Simplify Asset Management Inc. increased its holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 197.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 64,300 shares of the company’s stock after buying an additional 42,661 shares during the quarter. Simplify Asset Management Inc. owned about 0.23% of Establishment Labs worth $2,962,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. William Blair Investment Management LLC raised its holdings in shares of Establishment Labs by 44.1% during the fourth quarter. William Blair Investment Management LLC now owns 812,825 shares of the company’s stock worth $37,447,000 after purchasing an additional 248,888 shares during the last quarter. Bamco Inc. NY grew its position in Establishment Labs by 13.6% during the 3rd quarter. Bamco Inc. NY now owns 489,386 shares of the company’s stock worth $21,176,000 after purchasing an additional 58,611 shares during the period. Mudita Advisors LLP raised its stake in shares of Establishment Labs by 19.0% during the 3rd quarter. Mudita Advisors LLP now owns 354,801 shares of the company’s stock valued at $15,352,000 after buying an additional 56,700 shares during the last quarter. Assenagon Asset Management S.A. acquired a new position in shares of Establishment Labs in the 4th quarter valued at about $12,898,000. Finally, Redmile Group LLC boosted its stake in shares of Establishment Labs by 22.9% in the third quarter. Redmile Group LLC now owns 261,803 shares of the company’s stock worth $11,328,000 after buying an additional 48,779 shares during the last quarter. 72.91% of the stock is currently owned by institutional investors and hedge funds.

Establishment Labs Price Performance

NASDAQ:ESTA opened at $39.67 on Friday. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. Establishment Labs Holdings Inc. has a 52 week low of $28.16 and a 52 week high of $60.12. The stock’s 50-day moving average price is $35.70 and its 200-day moving average price is $40.86. The stock has a market capitalization of $1.14 billion, a PE ratio of -15.38 and a beta of 0.95.

Establishment Labs (NASDAQ:ESTA) last issued its quarterly earnings data on Wednesday, February 26th. The company reported ($0.98) EPS for the quarter, missing the consensus estimate of ($0.64) by ($0.34). The business had revenue of $44.51 million during the quarter, compared to analyst estimates of $44.45 million. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. As a group, equities analysts expect that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, Stephens reiterated an “overweight” rating and set a $52.00 price target on shares of Establishment Labs in a research report on Thursday, March 6th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $57.40.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.